pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
545
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
rexlemestrocel-L
Revascor (rexlemestrocel-L)
Hypoplastic Left Heart Syndrome
$MESO
MESOBLAST LTD
0
catalysts
Phase 3
ribupatide
ribupatide [INN]
Obesity
$KLRA
Kailera Therapeutics, Inc.
0
catalysts
Phase 3
riliprubart
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
$SNY
Sanofi
0
catalysts
← prev
page 16 of 19
next →
131
Pain
89
Neurology
1
Phase 3
rilparencel
Chronic Kidney Disease (Chronic Renal Failure)
$PROK
PROKIDNEY CORP.
0
catalysts
Phase 3
rinatabart sesutecan
Epithelial Ovarian Cancer
Genmab AS
0
catalysts
Phase 3
rinvecalinase alfa
Acute Ischemic Stroke
$DMAC
DiaMedica Therapeutics Inc.
0
catalysts
Phase 3
ripasudil hydrochloride
Fuchs Endothelial Corneal Dystrophy (FECD)
Rho-associated protein kinase
Kowa Co Ltd
0
catalysts
Phase 3
rivunatpagene miziparvovec
Wilson Disease
$RARE
Ultragenyx Pharmaceutical Inc.
0
catalysts
Phase 3
romiplostim
Nplate (romiplostim)
Thrombocytopenia
Thrombopoietin receptor
$AMGN
AMGEN INC
0
catalysts
Phase 3
romosozumab
Evenity (romosozumab-aqqg)
Osteogenesis Imperfecta
Sclerostin
$AMGN
AMGEN INC
0
catalysts
Phase 3
rostaporfin
Metastatic Breast Cancer
TuHURA Biosciences Inc
0
catalysts
Phase 3
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRK
Merck & Co., Inc.
0
catalysts
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVB
Nuvation Bio Inc.
0
catalysts
Phase 3
salanersen
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
0
catalysts
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Granulocyte-macrophage colony-stimulating factor receptor
Partner Therapeutics Inc
0
catalysts
Phase 3
saroglitazar magnesium
Lipaglyn (saroglitazar magnesium)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Zydus Therapeutics Inc
0
catalysts
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
IL6Ralpha/GP130
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 3
sefaxersen sodium
IgA Nephropathy (Berger's Disease)
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 3
selatogrel
selatogrel [INN]
Myocardial Infarction
Idorsia Pharmaceutical Ltd
0
catalysts
Phase 3
selenium sulfide
Selenium Sulfide (selenium sulfide [USP])
Meibomian Blepharitis
Azura Ophthalmics Pty Ltd
0
catalysts
Phase 3
seltorexant
Insomnia
Orexin receptor type 2
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptor
Macrophage colony-stimulating factor 1 receptor
$GOSS
Gossamer Bio, Inc.
0
catalysts
Phase 3
setrusumab
Osteogenesis Imperfecta
Sclerostin
$RARE
Ultragenyx Pharmaceutical Inc.
0
catalysts
Phase 3
sevasemten
Becker Muscular Dystrophy
$EWTX
Edgewise Therapeutics, Inc.
0
catalysts
Phase 3
simoladagene autotemcel
Adenosine Deaminase (ADA) Deficiency Related SCID
Rarity PBC
0
catalysts
Phase 3
sitravatinib malate
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 3
sodium benzoate
NaBen (sodium benzoate)
Schizophrenia
SyneuRx International (Taiwan) Corp
0
catalysts
Phase 3
sodium iodide
sodium iodide [USP]
Myocardial Infarction
Faraday Pharmaceuticals Inc
0
catalysts
Phase 3
sofetabart mipitecan
Fallopian Tube Cancer
Eli Lilly and Co
0
catalysts
Phase 3
sonelokimab
Psoriatic Arthritis
Interleukin-17A
Interleukin-17F
$MLTX
MoonLake Immunotherapeutics
0
catalysts